<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02602496</url>
  </required_header>
  <id_info>
    <org_study_id>UNebraskaLincolnFDST1</org_study_id>
    <nct_id>NCT02602496</nct_id>
  </id_info>
  <brief_title>Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals</brief_title>
  <official_title>Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals Through Intake of Whole Wheat Products in Comparison With Fruits and Vegetables</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska Lincoln</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska Lincoln</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the impact of increased intake of fruits and vegetables and whole grains
      on markers of inflammation and gut microbial composition. The treatment groups are 3 servings
      of whole grain per day; 5 servings of fruits and vegetables per day; and a control (3
      servings of refined grains per day provided).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Literature data suggests that fruits and vegetables and whole grains containing dietary fiber
      and other nutrients are important for maintaining beneficial microbes in the gut. The
      presence of beneficial microbes in the gut may mediate the subclinical inflammation
      experienced in metabolic disease. In this project, overweight or obese participants with low
      intakes of fruits and vegetables or whole grains will increase their intake of these foods to
      recommended levels. Changes in markers of inflammation and gut microbiota composition will be
      determined to assess and compare the potential impact of these foods on metabolic disease.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Interleukin-6 (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for interleukin-6 concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Tumor Necrosis Factor-α (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for tumor necrosis factor-α concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in High Sensitivity C-reactive Protein (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for high sensitivity C-reactive protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Lipopolysaccharide Binding Protein (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for lipopolysaccharide binding protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Gut Microbiota Shannon's Alpha Diversity (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>The Shannon Diversity Index is a quantitative measure that reflects how many different bacterial species there are in a sample. The greater the index, the more diverse the gut microbiota. A negative change indicates a decrease in diversity and a positive change indicates an increase in diversity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fecal Short Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Short-chain fatty acids (SCFAs) are the end products of fermentation of dietary fibers by the anaerobic intestinal microbiota. SCFAs have been shown to exert multiple beneficial effects on mammalian energy metabolism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Branched Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Branched chain fatty acids (BCFA) are mostly saturated fatty acids (SFA) with one or more methyl branches on the carbon chain. BCFAs were extracted from stool samples and measured using gas chromatography.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Body Mass Index (Value at Week 8 Minus Value at Week 0)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Body mass index will be measured on participants at the beginning (week 0) and end of the study (week 8). Changes in body mass index will be determined.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 servings of refined grains per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fruits and Vegetables</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 servings of fruits and vegetable per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole Grain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 servings of whole grains per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fruits and Vegetables</intervention_name>
    <description>5 servings of fruits or vegetables</description>
    <arm_group_label>Fruits and Vegetables</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole Grain</intervention_name>
    <description>3 servings of whole grain</description>
    <arm_group_label>Whole Grain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>3 servings of refined grain</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese or overweight men or women (body mass index, BMI, ≥25 kg/m2)

          -  Free of known gastrointestinal disease

          -  No supplements use (excluding multivitamin)

          -  Participate in less than 1 h of exercise per week

          -  Have not taken antibiotics in the last six months

        Exclusion Criteria:

          -  Men and women with fruits and vegetable intake exceeding 2 servings/day

          -  Men and women with whole grain intakes exceeding 1 serving/day

          -  Pregnant

          -  Do not fit the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Devin J Rose, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Food Innovation Center</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68588</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>November 4, 2015</study_first_submitted>
  <study_first_submitted_qc>November 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2015</study_first_posted>
  <results_first_submitted>November 27, 2017</results_first_submitted>
  <results_first_submitted_qc>February 7, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 10, 2019</results_first_posted>
  <last_update_submitted>May 22, 2019</last_update_submitted>
  <last_update_submitted_qc>May 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska Lincoln</investigator_affiliation>
    <investigator_full_name>Devin Rose</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Diet</keyword>
  <keyword>Whole grain</keyword>
  <keyword>Fruits</keyword>
  <keyword>Vegetables</keyword>
  <keyword>Gut health</keyword>
  <keyword>Anti-inflammatory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 27, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02602496/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 5, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02602496/ICF_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 23, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02602496/Prot_003.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
        </group>
        <group group_id="P2">
          <title>Fruits and Vegetables</title>
          <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
        </group>
        <group group_id="P3">
          <title>Whole Grain</title>
          <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
        </group>
        <group group_id="B2">
          <title>Fruits and Vegetables</title>
          <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
        </group>
        <group group_id="B3">
          <title>Whole Grain</title>
          <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="17"/>
            <count group_id="B4" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Only subjects that finished the study were included in the overall analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>Only subjects that finished the study were included in the analysis</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.6" spread="5.9"/>
                    <measurement group_id="B2" value="29.4" spread="12.8"/>
                    <measurement group_id="B3" value="39.2" spread="13.5"/>
                    <measurement group_id="B4" value="32.3" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Only subjects that finished the study were included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Interleukin-6</title>
          <population>Only subjects that finished the study were included in the analysis</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.6" spread="2"/>
                    <measurement group_id="B2" value="3.8" spread="2.2"/>
                    <measurement group_id="B3" value="4.7" spread="3.3"/>
                    <measurement group_id="B4" value="4.05" spread="2.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>high sensitivity C-reactive protein</title>
          <population>Only subjects that finished the study were included in the analysis</population>
          <units>mg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.65" spread="0.4"/>
                    <measurement group_id="B2" value="0.69" spread="0.39"/>
                    <measurement group_id="B3" value="0.79" spread="0.56"/>
                    <measurement group_id="B4" value="0.71" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>TNF-alpha</title>
          <population>Only subjects that finished the study were included in the analysis</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.8" spread="5.9"/>
                    <measurement group_id="B2" value="24.2" spread="5.2"/>
                    <measurement group_id="B3" value="26.7" spread="4.17"/>
                    <measurement group_id="B4" value="24.8" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>lipopolysaccharide binding protein</title>
          <population>Only subjects that finished the study were included in the analysis</population>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="14"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.83" spread="0.27"/>
                    <measurement group_id="B2" value="1.77" spread="0.45"/>
                    <measurement group_id="B3" value="1.90" spread="0.38"/>
                    <measurement group_id="B4" value="1.83" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Interleukin-6 (Value at Week 8 Minus Value at Week 0)</title>
        <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for interleukin-6 concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
        <time_frame>8 weeks</time_frame>
        <population>IL-6 was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Interleukin-6 (Value at Week 8 Minus Value at Week 0)</title>
          <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for interleukin-6 concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
          <population>IL-6 was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.45"/>
                    <measurement group_id="O2" value="-1.08" spread="0.52"/>
                    <measurement group_id="O3" value="0.51" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.9942</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.0062</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.6843</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Tumor Necrosis Factor-α (Value at Week 8 Minus Value at Week 0)</title>
        <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for tumor necrosis factor-α concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
        <time_frame>8 weeks</time_frame>
        <population>TNF-α was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Tumor Necrosis Factor-α (Value at Week 8 Minus Value at Week 0)</title>
          <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for tumor necrosis factor-α concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
          <population>TNF-α was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="1.58"/>
                    <measurement group_id="O2" value="-1.11" spread="1.13"/>
                    <measurement group_id="O3" value="-5.40" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.5096</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.2276</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.0006</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in High Sensitivity C-reactive Protein (Value at Week 8 Minus Value at Week 0)</title>
        <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for high sensitivity C-reactive protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
        <time_frame>8 weeks</time_frame>
        <population>C-reactive protein was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in High Sensitivity C-reactive Protein (Value at Week 8 Minus Value at Week 0)</title>
          <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for high sensitivity C-reactive protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
          <population>C-reactive protein was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
          <units>mg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.08"/>
                    <measurement group_id="O2" value="-0.06" spread="0.06"/>
                    <measurement group_id="O3" value="0.00" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.9708</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.1642</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.6043</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Lipopolysaccharide Binding Protein (Value at Week 8 Minus Value at Week 0)</title>
        <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for lipopolysaccharide binding protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
        <time_frame>8 weeks</time_frame>
        <population>Lipopolysaccharide binding protein was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lipopolysaccharide Binding Protein (Value at Week 8 Minus Value at Week 0)</title>
          <description>Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for lipopolysaccharide binding protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.</description>
          <population>Lipopolysaccharide binding protein was analyzed using an ELISA kit. The mean outcome is the mean of difference between the end and beginning of the treatment period.</population>
          <units>mcg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.07"/>
                    <measurement group_id="O2" value="-0.21" spread="0.07"/>
                    <measurement group_id="O3" value="-0.21" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.0868</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.0083</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.0151</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Gut Microbiota Shannon's Alpha Diversity (Value at Week 8 Minus Value at Week 0)</title>
        <description>The Shannon Diversity Index is a quantitative measure that reflects how many different bacterial species there are in a sample. The greater the index, the more diverse the gut microbiota. A negative change indicates a decrease in diversity and a positive change indicates an increase in diversity.</description>
        <time_frame>8 weeks</time_frame>
        <population>Alpha diversity was analyzed through the Shannon's Index. The mean outcome is the mean difference between the end and beginning of the treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gut Microbiota Shannon's Alpha Diversity (Value at Week 8 Minus Value at Week 0)</title>
          <description>The Shannon Diversity Index is a quantitative measure that reflects how many different bacterial species there are in a sample. The greater the index, the more diverse the gut microbiota. A negative change indicates a decrease in diversity and a positive change indicates an increase in diversity.</description>
          <population>Alpha diversity was analyzed through the Shannon's Index. The mean outcome is the mean difference between the end and beginning of the treatment period.</population>
          <units>Shannon's Index</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.15"/>
                    <measurement group_id="O2" value="0.12" spread="0.09"/>
                    <measurement group_id="O3" value="-0.15" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.9255</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.0454</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.2920</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Fecal Short Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)</title>
        <description>Short-chain fatty acids (SCFAs) are the end products of fermentation of dietary fibers by the anaerobic intestinal microbiota. SCFAs have been shown to exert multiple beneficial effects on mammalian energy metabolism.</description>
        <time_frame>8 weeks</time_frame>
        <population>Mean outcome is the mean difference between the beginning and end of the study. SCFAs were extracted from stool samples and measured using gas chromatography.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fecal Short Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)</title>
          <description>Short-chain fatty acids (SCFAs) are the end products of fermentation of dietary fibers by the anaerobic intestinal microbiota. SCFAs have been shown to exert multiple beneficial effects on mammalian energy metabolism.</description>
          <population>Mean outcome is the mean difference between the beginning and end of the study. SCFAs were extracted from stool samples and measured using gas chromatography.</population>
          <units>mmol/g</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-45.82" spread="22.50"/>
                    <measurement group_id="O2" value="10.72" spread="13.50"/>
                    <measurement group_id="O3" value="2.88" spread="10.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.2252</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.4715</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.7157</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Branched Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)</title>
        <description>Branched chain fatty acids (BCFA) are mostly saturated fatty acids (SFA) with one or more methyl branches on the carbon chain. BCFAs were extracted from stool samples and measured using gas chromatography.</description>
        <time_frame>8 weeks</time_frame>
        <population>The outcome mean is the mean difference between the beginning and the end of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Branched Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)</title>
          <description>Branched chain fatty acids (BCFA) are mostly saturated fatty acids (SFA) with one or more methyl branches on the carbon chain. BCFAs were extracted from stool samples and measured using gas chromatography.</description>
          <population>The outcome mean is the mean difference between the beginning and the end of the study.</population>
          <units>mmol/g</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.60"/>
                    <measurement group_id="O2" value="-2.41" spread="2.79"/>
                    <measurement group_id="O3" value="0.16" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.8323</p_value>
            <p_value_desc>Corrected for baseline concentrations, age, gender, and body mass index</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.8927</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.3173</p_value>
            <method>ANOVA</method>
            <method_desc>Corrected for baseline concentrations, age, gender, and body mass index</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Body Mass Index (Value at Week 8 Minus Value at Week 0)</title>
        <description>Body mass index will be measured on participants at the beginning (week 0) and end of the study (week 8). Changes in body mass index will be determined.</description>
        <time_frame>8 weeks</time_frame>
        <population>Weight and height were measured to calculate the BMI. The outcome mean is the mean difference between the beginning and end of the treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
          </group>
          <group group_id="O2">
            <title>Fruits and Vegetables</title>
            <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
          </group>
          <group group_id="O3">
            <title>Whole Grain</title>
            <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Body Mass Index (Value at Week 8 Minus Value at Week 0)</title>
          <description>Body mass index will be measured on participants at the beginning (week 0) and end of the study (week 8). Changes in body mass index will be determined.</description>
          <population>Weight and height were measured to calculate the BMI. The outcome mean is the mean difference between the beginning and end of the treatment period.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.09"/>
                    <measurement group_id="O2" value="-0.22" spread="0.25"/>
                    <measurement group_id="O3" value="-0.12" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Value at week 8 minus value at week 0</non_inferiority_desc>
            <p_value>0.27</p_value>
            <p_value_desc>Corrected for baseline concentrations, age and gender</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 Weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>3 servings of refined grains per day.
Control: 3 servings of refined grain</description>
        </group>
        <group group_id="E2">
          <title>Fruits and Vegetables</title>
          <description>5 servings of fruits and vegetable per day.
Fruits and Vegetables: 5 servings of fruits or vegetables</description>
        </group>
        <group group_id="E3">
          <title>Whole Grain</title>
          <description>3 servings of whole grains per day.
Whole Grain: 3 servings of whole grain</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Devin Rose</name_or_title>
      <organization>University of Nebraska Lincoln</organization>
      <phone>402-472-2802</phone>
      <email>drose3@unl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

